Bryan Norman Special Seminar
Purdue Institute for Drug Discovery
March 5, 2018
11:00 AM - 12:00 PM
DRUG Lobby Conference Room
Description
Bryan Norman, recently retired from Eli Lilly, is presenting a Special Drug Discovery Seminar titled “Discovery and clinical evaluation of mPGES1 inhibitors as anti-inflammatory agents using translatable biomarkers to assess target engagement, specificity, efficacy and safety”.
Dr. Norman's recent research interests have focused on the discovery of novel analgesic agents for use in chronic pain.
Contact Details
- Stephanie Winder
- winder@purdue.edu
- 496-0364